Point mutations in the isocitrate dehydrogenase 1 (IDH1) and IDH2 genes occur in up to 80% of grade II and III oligodendrogliomas, astrocytomas, and secondary glioblastomas. We developed iDDS probes against some of the most common oncogenic mutations in IDH1 (R132H, R132C) and IDH2 (R172K, R172M).
Our IDH1 and iDH2 assays performed well with formalin-fixed, paraffin-embedded brain tumor specimens, as shown below.
GeneTAG Technology, Inc.
Copyright © 2023 GeneTAG Technology - All Rights Reserved.
Powered by GoDaddy